Optimization of de novo belatacept‐based immunosuppression administered to renal transplant recipients
出版年份 2020 全文链接
标题
Optimization of de novo belatacept‐based immunosuppression administered to renal transplant recipients
作者
关键词
-
出版物
AMERICAN JOURNAL OF TRANSPLANTATION
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2020-11-01
DOI
10.1111/ajt.16386
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- OPTN / SRTR 2018 Annual Data Report: Kidney
- (2020) A. Hart et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Kidney transplantation using alemtuzumab, belatacept, and sirolimus: Five‐year follow‐up
- (2020) Robin Schmitz et al. AMERICAN JOURNAL OF TRANSPLANTATION
- CMV high‐risk status and posttransplant outcomes in kidney transplant recipients treated with belatacept
- (2020) Geeta Karadkhele et al. AMERICAN JOURNAL OF TRANSPLANTATION
- An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients
- (2019) Claudia Sommerer et al. KIDNEY INTERNATIONAL
- OPTN/SRTR 2017 Annual Data Report: Kidney
- (2019) A. Hart et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Two‐year outcomes in de novo renal transplant recipients receiving everolimus‐facilitated calcineurin inhibitor reduction regimen from the TRANSFORM study
- (2019) Stefan P. Berger et al. AMERICAN JOURNAL OF TRANSPLANTATION
- mTOR Inhibitor Therapy Diminishes Circulating CD8+ CD28- Effector Memory T Cells and Improves Allograft Inflammation in Belatacept-Refractory Renal Allograft Rejection
- (2019) Cyd M. Castro-Rojas et al. TRANSPLANTATION
- Belatacept‐Based Immunosuppression With Simultaneous Calcineurin Inhibitor Avoidance and Early Corticosteroid Withdrawal: A Prospective, Randomized Multicenter Trial
- (2019) E. Steve Woodle et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Posttransplant reduction in preexisting donor-specific antibody levels after belatacept- versus cyclosporine-based immunosuppression: Post hoc analyses of BENEFIT and BENEFIT-EXT
- (2018) R. A. Bray et al. AMERICAN JOURNAL OF TRANSPLANTATION
- De novo donor-specific antibodies in belatacept-treated vs cyclosporine-treated kidney-transplant recipients: Post hoc analyses of the randomized phase III BENEFIT and BENEFIT-EXT studies
- (2018) R. A. Bray et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Outcomes at 7 years post-transplant in black vs nonblack kidney transplant recipients administered belatacept or cyclosporine in BENEFIT and BENEFIT-EXT
- (2018) Sander Florman et al. CLINICAL TRANSPLANTATION
- Glucocorticoids use in kidney transplant setting
- (2018) Débora Dias de Lucena et al. Expert Opinion on Drug Metabolism & Toxicology
- Methylation of FOXP3 TSDR Underlies the Impaired Suppressive Function of Tregs from Long-term Belatacept-Treated Kidney Transplant Patients
- (2017) Evelyn Katy Alvarez Salazar et al. Frontiers in Immunology
- Long-Term Outcomes in Belatacept- Versus Cyclosporine-Treated Recipients of Extended Criteria Donor Kidneys: Final Results From BENEFIT-EXT, a Phase III Randomized Study
- (2016) A. Durrbach et al. AMERICAN JOURNAL OF TRANSPLANTATION
- CD57+CD4 T Cells Underlie Belatacept-Resistant Allograft Rejection
- (2016) J. Espinosa et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Reduced Racial Disparity in Kidney Transplant Outcomes in the United States from 1990 to 2012
- (2016) T. S. Purnell et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Memory T cells in organ transplantation: progress and challenges
- (2016) Jaclyn R. Espinosa et al. Nature Reviews Nephrology
- Belatacept and Long-Term Outcomes in Kidney Transplantation
- (2016) Flavio Vincenti et al. NEW ENGLAND JOURNAL OF MEDICINE
- mTOR inhibitor versus mycophenolic acid as the primary immunosuppression regime combined with calcineurin inhibitor for kidney transplant recipients: a meta-analysis
- (2015) Xishao Xie et al. BMC Nephrology
- CD28 Negative T Cells: Is Their Loss Our Gain?
- (2014) D. Mou et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Renal Transplantation Using Belatacept Without Maintenance Steroids or Calcineurin Inhibitors
- (2014) A. D. Kirk et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Cardiovascular morbidity and mortality after kidney transplantation
- (2014) Sokratis Stoumpos et al. TRANSPLANT INTERNATIONAL
- Long-Term Exposure to Belatacept in Recipients of Extended Criteria Donor Kidneys
- (2013) B. Charpentier et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Long-Term Belatacept Exposure Maintains Efficacy and Safety at 5 Years: Results From the Long-Term Extension of the BENEFIT Study
- (2013) L. Rostaing et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Three-Year Outcomes From BENEFIT-EXT: A Phase III Study of Belatacept Versus Cyclosporine in Recipients of Extended Criteria Donor Kidneys
- (2012) J. O. Medina Pestana et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Three-Year Outcomes from BENEFIT, a Randomized, Active-Controlled, Parallel-Group Study in Adult Kidney Transplant Recipients
- (2011) F. Vincenti et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Costimulatory blockade with mTor inhibition abrogates effector T-cell responses allowing regulatory T-cell survival in renal transplantation
- (2011) Oriol Bestard et al. TRANSPLANT INTERNATIONAL
- Immunosuppression with Belatacept-Based, Corticosteroid-Avoiding Regimens in De Novo Kidney Transplant Recipients
- (2010) R. Ferguson et al. AMERICAN JOURNAL OF TRANSPLANTATION
- A Phase III Study of Belatacept Versus Cyclosporine in Kidney Transplants from Extended Criteria Donors (BENEFIT-EXT Study)
- (2010) A. Durrbach et al. AMERICAN JOURNAL OF TRANSPLANTATION
- A Phase III Study of Belatacept-based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study)
- (2010) F. Vincenti et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Overcoming the memory barrier in tolerance induction: molecular mimicry and functional heterogeneity among pathogen-specific T-cell populations
- (2010) Mandy L Ford et al. Current Opinion in Organ Transplantation
- Optimal immunosuppression to prevent chronic allograft dysfunction
- (2010) Josep M. Grinyó et al. KIDNEY INTERNATIONAL
- Mechanism of cellular rejection in transplantation
- (2008) Elizabeth Ingulli PEDIATRIC NEPHROLOGY
- Immunosuppressive medications, clinical and metabolic parameters in new-onset diabetes mellitus after kidney transplantation
- (2008) Mélanie Roland et al. TRANSPLANT INTERNATIONAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now